GP KFPs / SAQs · gastrointestinal-health
Dyspepsia, reflux, and Helicobacter pylori — KFP-style written assessment
KFP-style staged scenarios on dyspepsia and reflux: applying the alarm list, the test-and-treat strategy with PPI washout, eradication regimen selection under resistance, GORD step-down with rebound warning, and honest lifestyle counselling.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
The burning epigastrium: alarms first, test-and-treat second, honest numbers always
KFP 1 (10 marks)
A 47-year-old woman presents with three months of epigastric pain and early satiation. She has no dysphagia, no vomiting, no bleeding, normal blood count, and is not on NSAIDs. Her sister recently had gastric cancer diagnosed at 60. [3]
- List the alarm features that would have mandated urgent endoscopy regardless of age. (4) [1]
- In her case, what is the recommended pathway and which tests are acceptable? (3) [1]
- What does the endoscopy literature predict she would find if scoped — quote the prevalence data. (3) [3]
Model answers
- Dysphagia; persistent vomiting; GI bleeding or iron-deficiency anaemia; unintentional weight loss; epigastric mass; new or worsening symptoms despite treatment. New dyspepsia at 55+ with anaemia, raised platelets, nausea/vomiting, weight loss or family history of upper GI cancer also warrants endoscopy. [1]
- Under 60 without alarm features: test-and-treat. Urea breath test (pooled sensitivity 0.96, specificity 0.93) or monoclonal stool antigen test (sensitivity 0.94, specificity 0.97); serology alone is unacceptable because it cannot distinguish active from past infection. Stop PPIs two weeks before testing. [1] [4]
- More than 85% of endoscopies in uninvestigated community dyspepsia are completely normal; erosive oesophagitis is the most common abnormality (pooled prevalence 11.0%), peptic ulcer next (4.4%); gastro-oesophageal cancer is rare (below 0.4%) and equally prevalent with and without dyspepsia. [3]
References7ShowHide
- [1]Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report Gut, 2022.PMID 35944925
- [2]Ford AC, Gurusamy KS, Delaney B, et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people Cochrane Database Syst Rev, 2016.PMID 27092708
- [3]Ford AC, Marwaha A, Lim A, et al. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Updated systematic review and meta-analysis Clin Gastroenterol Hepatol, 2023.PMID 35738355
- [4]Saeed MA, Shafique N, Ishaq U, et al. Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis World J Gastroenterol, 2015.PMID 25632206
- [5]Reimer C, Sondergaard B, Hilsted L, et al. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy Gastroenterology, 2009.PMID 19362552
- [6]Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle Intervention in Gastroesophageal Reflux Disease Clin Gastroenterol Hepatol, 2016.PMID 25956834
- [7]Ford AC, Ching JY, Gerson LB, et al. Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis Gut, 2022.PMID 35022266